Health Sciences Acquisitions Corporation 2 – NASDAQ:HSAQ

Financial Health
0
1
2
3
4
5
6
7
8
9

Health Sciences Acquisitions Corporation 2 stock price monthly change

+33.50%
month

Health Sciences Acquisitions Corporation 2 stock price quarterly change

+33.30%
quarter

Health Sciences Acquisitions Corporation 2 stock price yearly change

+34.99%
year

Health Sciences Acquisitions Corporation 2 key metrics

Market Cap
 149.23M
Enterprise value
 N/A
P/E
 -532.4
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 -31.48
PEG ratio
 0.66
EPS
 -0.08
Revenue
 N/A
EBITDA
 -39.90M
Income
 -36.17M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Health Sciences Acquisitions Corporation 2 stock price history

Health Sciences Acquisitions Corporation 2 stock forecast

Health Sciences Acquisitions Corporation 2 financial statements

Profit Margin

Health Sciences Acquisitions Corporation 2 (NASDAQ:HSAQ): Profit margin
Dec 2022 0 -1.36M
Mar 2023 1.16M -9.45M -811.86%
Jun 2023 915K -12.04M -1316.5%
Sep 2023 419K -13.31M -3178.04%
HSAQ income statement history

Debt to Assets

Health Sciences Acquisitions Corporation 2 (NASDAQ:HSAQ): Debt to assets
Dec 2022 68075577 7.34M 10.79%
Mar 2023 136281000 36.52M 26.8%
Jun 2023 125883000 36.44M 28.95%
Sep 2023 116357000 36.70M 31.54%
HSAQ balance sheet history

Cash Flow

Health Sciences Acquisitions Corporation 2 (NASDAQ:HSAQ): Cash Flow
Dec 2022 -560.05K 92.59M -92.59M
Mar 2023 -14.38M -43.52M 56.82M
Jun 2023 0 0 0
Sep 2023 0 0 0
HSAQ cash flow history

Health Sciences Acquisitions Corporation 2 other data

Health Sciences Acquisitions Corporation 2
Insider Trading

Health Sciences Acquisitions Corporation 2 (NASDAQ:HSAQ): Insider trades (number of shares)
Period Buy Sel
Jul 2022 1000000 0
Jan 2023 1815347 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
ROSE ERIC A MD director
 Common Stock, par value $0.0001 per share ("Common Stock") 2,325 $1.08 $2,511
Option
ROSE ERIC A MD director
 Warrant (Right to Buy) 2,325 $1.08 $2,511
Option
FAIN ERIC S director
 Common Stock, par value $0.0001 per share ("Common Stock") 2,906 $1.08 $3,138
Option
FAIN ERIC S director
 Warrant (Right to Buy) 2,906 $1.08 $3,138
Purchase
MEDTRONIC PLC 10 percent owner
 Common Stock 6,835 $9.28 $63,436
Purchase
WONG RODERICK director, 10 percent owner, off..
 Ordinary Shares 1,808,512 $10 $18,085,120
Purchase
WONG RODERICK director, officer: Chief Execut..
 Ordinary Shares 1,000,000 $10.01 $10,010,000
Purchase
HSAC 2 HOLDINGS, LLC 10 percent owner
 Warrants to purchase Ordinary Shares 1,500,000 $11.5 $17,250,000
Purchase
HSAC 2 HOLDINGS, LLC 10 percent owner
 Ordinary Shares 450,000 $10 $4,500,000
Purchase
SIROTA STEPHANIE A officer: VP of Corp Stratege an..
 Ordinary Shares 20,000 $10 $200,000
HSAQ insider trading transactions

Frequently Asked Questions (FAQ)

  • When is Health Sciences Acquisitions Corporation 2's next earnings date?

    Unfortunately, Health Sciences Acquisitions Corporation 2's (HSAQ) next earnings date is currently unknown.

  • Does Health Sciences Acquisitions Corporation 2 pay dividends?

    No, Health Sciences Acquisitions Corporation 2 does not pay dividends.

  • How much money does Health Sciences Acquisitions Corporation 2 make?

    Health Sciences Acquisitions Corporation 2 has a market capitalization of 149.23M.

  • What is Health Sciences Acquisitions Corporation 2's stock symbol?

    Health Sciences Acquisitions Corporation 2 is traded on the NASDAQ under the ticker symbol "HSAQ".

  • What is Health Sciences Acquisitions Corporation 2's primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Health Sciences Acquisitions Corporation 2?

    Shares of Health Sciences Acquisitions Corporation 2 can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Health Sciences Acquisitions Corporation 2 went public?

    Health Sciences Acquisitions Corporation 2 is publicly traded company for more then 5 years since IPO on 4 Aug 2020.

  • Where are Health Sciences Acquisitions Corporation 2's headquarters?

    Health Sciences Acquisitions Corporation 2 is headquartered at 40 10th Avenue, New York, NY.

  • How can i contact Health Sciences Acquisitions Corporation 2?

    Health Sciences Acquisitions Corporation 2's mailing address is 40 10th Avenue, New York, NY and company can be reached via phone at +64 6 597 6980.

Health Sciences Acquisitions Corporation 2 company profile:

Health Sciences Acquisitions Corporation 2

Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

+64 6 597 6980
40 10th Avenue
New York, NY 10014

CIK: 0001814114
ISIN: KYG4411D1097
CUSIP: G4411D109